MTF1 Antibody

What is MTF1 and what are its key cellular functions?

MTF1 is a highly conserved zinc-binding transcription factor that recognizes and binds to metal-responsive elements (MREs) characterized by the -TGCRCNC- consensus sequence located near promoters of genes related to redox and metal homeostasis . It functions primarily to promote the transcription of genes that maintain metal homeostasis and responds to both metal excess and deprivation . MTF1's transcriptional activity is associated with the availability of zinc ions, though the precise molecular mechanisms by which metals activate MTF1 remain under investigation .

Beyond metal homeostasis, MTF1 plays essential roles in protecting cells from oxidative and hypoxic stresses and is required for embryonic development in vertebrates . Recent research has also revealed MTF1's importance in cell differentiation processes, particularly in myogenesis, where both its expression and nuclear localization increase upon differentiation initiation .

What types of MTF1 antibodies are available for research applications?

MTF1 antibodies are available in multiple configurations to accommodate diverse research needs:

When selecting an MTF1 antibody, researchers should consider the specific amino acid region being targeted, as this may affect detection capabilities depending on protein conformation, post-translational modifications, or protein-protein interactions in the experimental context .

What are the recommended applications for studying MTF1 in different experimental contexts?

MTF1 can be studied using various techniques depending on the research question:

• Subcellular Localization Studies: Immunofluorescence (IF) is particularly valuable for monitoring MTF1 nuclear translocation in response to metal stimulation or during differentiation processes. For optimal results, use glass-bottom culture dishes and fix cells in 10% formalin, followed by permeabilization with phosphate-buffered triton (PBT) buffer (0.5% Triton X-100 in PBS) .

• Protein Expression Analysis: Western blotting (WB) is effective for quantifying MTF1 protein levels across different conditions or comparing expression between normal and pathological tissues .

• Chromatin Binding Studies: ChIP-seq approaches can identify MTF1 binding sites on DNA and reveal downstream gene targets regulated by this transcription factor .

• Tissue Expression Patterns: Immunohistochemistry (IHC) is recommended for examining MTF1 expression patterns in tissue sections, particularly when investigating its role in cancer progression .

• Protein-Protein Interactions: Immunoprecipitation (IP) allows researchers to study MTF1's interaction with other proteins involved in metal homeostasis regulation .

How does MTF1 expression correlate with clinical outcomes in cancer research?

MTF1 expression demonstrates context-dependent associations with clinical outcomes across different cancer types:

These contradictory associations suggest tissue-specific functions of MTF1 and highlight the importance of contextual analysis when evaluating MTF1 as a prognostic biomarker .

What methodological approaches are recommended for investigating MTF1's role in cuproptosis?

Cuproptosis is a recently discovered copper-dependent cell death mechanism involving direct binding of copper to lipoylated components of the tricarboxylic acid (TCA) cycle, resulting in the aggregation of lipoylated proteins, loss of iron-sulfur clusters, proteotoxic stress, and ultimately cell death . MTF1 has been identified as a potential resistance factor to cuproptosis .

To investigate MTF1's role in cuproptosis:

• Gene Manipulation Approaches: Utilize shRNA knockdown or CRISPR/Cas9 knockout of MTF1 followed by copper treatment to assess changes in cell sensitivity to cuproptosis . For shRNA viral production, Mission plasmids encoding different shRNAs against MTF1 can be used .

• Functional Assays: After MTF1 knockdown, measure:

  • Cell proliferation rates

  • Reactive oxygen species (ROS) levels

  • Cell death markers

  • Mitochondrial function parameters

• Molecular Mechanism Investigation: Examine the expression of lipoylated proteins in the TCA cycle and assess protein aggregation in the presence and absence of MTF1 .

• Recovery Experiments: Perform rescue experiments by reintroducing wild-type MTF1 or mutant variants (particularly mutations in the copper-binding site) to determine the specific domains required for cuproptosis resistance .

How can researchers optimize immunofluorescence protocols for studying MTF1 nuclear translocation?

MTF1 nuclear translocation is a critical aspect of its activation mechanism. To optimize immunofluorescence protocols for studying this process:

• Cell Culture Conditions: Grow primary cells on glass bottom culture dishes (e.g., Cellview Advanced TC culture dishes) to ensure optimal imaging quality .

• Fixation and Permeabilization:

  • Fix cells in 10% formalin

  • Permeabilize with phosphate-buffered triton (PBT) buffer (0.5% Triton X-100 in PBS)

  • Block in 5% horse serum in PBT

• Antibody Selection and Dilution:

  • Primary antibody: Use rabbit anti-MTF1 or anti-FLAG antibodies at 1:100 dilution in blocking solution

  • Incubate overnight at 4°C

  • Secondary antibody: Goat anti-rabbit Alexa-488 at 1:500 dilution for 2 hours at room temperature

  • DAPI staining for 30 minutes for nuclear visualization

• Time Course Analysis: Examine cells at different time points (e.g., proliferation phase and 24, 48, and 72 hours after induction of differentiation) to track dynamic changes in MTF1 localization .

• Controls: Include both positive controls (cells treated with zinc or copper to induce translocation) and negative controls (MTF1 knockdown cells) to validate antibody specificity .

What approaches should be used to study MTF1's relationship with immune infiltration in tumors?

Recent research has revealed significant correlations between MTF1 expression and immune cell infiltration in tumors. To investigate this relationship:

• Bioinformatic Analysis:

  • Utilize single sample gene set enrichment analysis (ssGSEA) algorithms to evaluate correlations between MTF1 expression and immune cell populations

  • The TIMER2.0 database can be employed to assess correlations across multiple cancer types in TCGA data

• Specific Immune Cell Types to Analyze:

  • Plasmacytoid dendritic cells (pDC)

  • Central memory T cells (Tcm)

  • CD8+ T cells

  • Regulatory T cells (Tregs)

  • Cancer-associated fibroblasts (CAF)

  • Natural killer (NK) cells

  • B cells

  • Macrophages

• Experimental Validation:

  • Co-immunofluorescence staining of MTF1 with immune cell markers in tissue sections

  • Flow cytometry analysis of immune cell populations in MTF1-high versus MTF1-low tumors

  • In vitro co-culture systems of cancer cells (with modulated MTF1 expression) and immune cells to assess functional interactions

• Functional Impact Assessment:

  • Analyze expression of immune checkpoint molecules in relation to MTF1 expression

  • Evaluate cytokine/chemokine production profiles

  • Assess T cell cytotoxicity against cancer cells with varying MTF1 expression levels

What strategies are recommended for validating MTF1 knockdown or knockout efficiency?

When manipulating MTF1 expression for functional studies, rigorous validation of knockdown or knockout efficiency is essential:

• Multiple Validation Methods:

  • Western blotting: Quantify protein level reduction

  • RT-qPCR: Measure mRNA expression levels

  • Immunofluorescence: Visualize reduction in protein expression at the cellular level

• CRISPR/Cas9 Knockout Validation:

  • Design sgRNAs targeting MTF1 (consider using the empty plasmid expressing only Cas9 but no sgRNA as a null knockout control)

  • Confirm genome editing by DNA sequencing of the target region

  • Validate knockout at protein level using antibodies targeting different epitopes of MTF1

• shRNA Knockdown Validation:

  • Use at least two different shRNA sequences targeting different regions of MTF1 mRNA

  • Include appropriate control shRNAs (non-targeting)

  • Quantify knockdown efficiency by densitometry analysis of Western blots

• Rescue Experiments:

  • Generate retroviral constructs for wild-type MTF1 or mutant variants (e.g., MBS mutant)

  • Confirm expression of the rescue construct by detection of attached tags (e.g., C-terminal FLAG tag)

  • Demonstrate functional rescue of the knockdown/knockout phenotype

How can researchers effectively study the impact of metal availability on MTF1 function?

MTF1's primary function involves sensing and responding to metal levels, particularly zinc. To study how metal availability affects MTF1 function:

• Metal Supplementation and Chelation Experiments:

  • Supplement culture media with physiologically relevant concentrations of zinc, copper, or other metals

  • Use metal-specific chelators to create metal-deficient conditions

  • Measure MTF1 nuclear translocation, DNA binding, and target gene expression under these varied conditions

• Mutation Studies:

  • Introduce mutations in the putative metal-binding sites (MBS) of MTF1 using site-directed mutagenesis

  • The carboxy-terminal copper-binding site can be mutated by substituting key residues with alanine

  • Express these mutant versions in MTF1-knockout backgrounds to assess functional consequences

• Structural Analysis:

  • Recombinant protein expression systems can be used to produce wild-type and mutant MTF1 proteins

  • GST-tagged MTF1 constructs facilitate purification for in vitro metal-binding studies

  • Compare the metal-binding properties and conformational changes between wild-type and mutant proteins

• Metallomics Approach:

  • Employ atomic absorbance spectroscopy to quantify cellular metal content

  • Correlate changes in metal homeostasis with MTF1 activity

  • Analyze metal distribution in subcellular compartments in relation to MTF1 localization

What are the best approaches for studying MTF1's role in cell differentiation?

MTF1 has been implicated in cell differentiation processes, particularly in myogenesis. To investigate this role:

• Differentiation Models:

  • Primary myoblasts offer an excellent model for studying MTF1's role in differentiation

  • Observe changes in MTF1 expression and localization during proliferation and at 24, 48, and 72 hours after induction of differentiation

• Combined Techniques:

  • Implement multiple experimental strategies including gene knockdown (shRNA), CRISPR/Cas9 knockout, immunofluorescence, ChIP-seq, subcellular fractionation, and atomic absorbance spectroscopy for a comprehensive analysis

• ChIP-Seq Analysis:

  • Identify MTF1 binding sites before and during differentiation

  • Analyze changes in the MTF1 cistrome during the differentiation process

  • Correlate binding sites with expression changes of nearby genes

• Functional Recovery:

  • After MTF1 knockdown or knockout, attempt to rescue differentiation defects by reintroducing wild-type or mutant MTF1 variants

  • This approach can identify specific domains or activities of MTF1 required for the differentiation process

How should researchers approach single-cell analysis of MTF1 expression and function?

Single-cell sequencing technologies offer valuable insights into heterogeneous MTF1 expression and function:

• Single-Cell Expression Profiling:

  • Single-cell RNA sequencing can reveal cell-type-specific expression patterns of MTF1

  • This approach has indicated that MTF1 is associated with angiogenesis, DNA repair, and cell invasion pathways at the single-cell level

• Clinical Sample Analysis:

  • Apply single-cell approaches to clinical samples to correlate MTF1 expression with specific cell populations in the tumor microenvironment

  • This can reveal associations between MTF1 expression and cancer stem cells or therapy-resistant subpopulations

• Spatial Transcriptomics:

  • Combine MTF1 expression data with spatial information to understand its role in tissue architecture and cell-cell interactions

  • This is particularly relevant for studying MTF1's relationship with immune cell infiltration in the tumor microenvironment

• Functional Heterogeneity:

  • Single-cell protein analysis techniques can reveal functional heterogeneity in MTF1 activation and nuclear translocation

  • This may identify subpopulations of cells with differential responses to metal stress or therapeutic interventions

What methodological considerations are important when studying MTF1 in different cancer types?

Given MTF1's contradictory prognostic associations across cancer types, researchers should consider:

• Cancer-Type Specific Analysis:

  • High MTF1 expression correlates with poor prognosis in liver hepatocellular carcinoma (LIHC) and brain lower grade glioma (LGG)

  • Conversely, high MTF1 expression is associated with good prognosis in kidney renal clear cell carcinoma (KIRC), lung cancer, ovarian cancer, and breast cancer

  • These contradictions necessitate cancer-type specific analysis approaches

• Combined Genomic and Epigenomic Analysis:

  • Investigate genetic alterations and methylation levels of MTF1 between primary tumors and normal tissues

  • These molecular characteristics may explain the diverse prognostic implications across cancer types

• Pathway Analysis:

  • MTF1-interacted molecules participate in metabolism-related pathways, including peptidyl-serine phosphorylation, negative regulation of cellular amide metabolic process, and peptidyl-threonine phosphorylation

  • Focus analysis on these pathways to understand cancer-specific functions

• In Vitro Functional Studies:

  • Knockdown experiments in cancer cell lines (such as HepG2 and Huh7 for LIHC) have demonstrated that MTF1 depletion suppresses cell proliferation, increases reactive oxygen species (ROS), and promotes cell death

  • Select appropriate cell line models representative of the cancer type being studied

What are the common challenges in MTF1 antibody applications and how can they be addressed?

Researchers working with MTF1 antibodies may encounter several technical challenges:

• Background Signal Issues:

  • Problem: High background in immunostaining or Western blot applications

  • Solution: Optimize blocking conditions (try 5% horse serum in PBT buffer), increase washing steps, and titrate antibody concentration

• Detection Sensitivity:

  • Problem: Weak signal when detecting endogenous MTF1

  • Solution: Consider signal amplification methods, use antibodies targeting different epitopes, or employ more sensitive detection systems

• Specificity Concerns:

  • Problem: Cross-reactivity with other proteins

  • Solution: Validate antibody specificity using MTF1 knockout or knockdown samples as negative controls

  • For immunofluorescence, include secondary antibody-only controls to rule out non-specific binding

• Nuclear Translocation Detection:

  • Problem: Difficulty distinguishing cytoplasmic versus nuclear localization

  • Solution: Use confocal microscopy with appropriate nuclear counterstaining (DAPI) and perform subcellular fractionation followed by Western blotting as a complementary approach

What controls should be included in MTF1 functional studies?

Appropriate controls are essential for reliable MTF1 research:

• Expression Manipulation Controls:

  • For knockdown: Non-targeting shRNA control

  • For CRISPR/Cas9: Empty plasmid expressing Cas9 but no sgRNA (null knockout control)

  • For overexpression: Empty vector control

• Rescue Controls:

  • Wild-type MTF1 rescue to confirm specificity of observed phenotypes

  • Functionally impaired MTF1 mutants (e.g., mutations in the metal-binding site) to identify essential domains

• Metal Response Controls:

  • Metal chelator treatments to establish baseline in metal response studies

  • Metal supplementation positive controls

  • Time course controls to capture dynamic responses

• Antibody Controls:

  • For immunostaining: Secondary antibody-only controls

  • Isotype controls for monoclonal antibodies

  • Peptide competition assays to confirm specificity

• Cell Type Controls:

  • Compare results across multiple cell lines or primary cells

  • Include both MTF1-high and MTF1-low expressing cell types when available